Dana Investment Advisors, Inc.

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1427514 BROOKFIELD, WI

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,974,365

+$300,832 QoQ

Shares Held

3,677

+15.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#161

of 414 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. MDGL ranks #6 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	57,520	$18,181,496
2	AXSM	Axsome Therapeutics, Inc.	22,850	$5,592,994
3	REGN	Regeneron Pharmaceuticals, Inc.	7,719	$4,813,105
4	TGTX	Tg Therapeutics, Inc.	42,012	$2,308,139
5	VKTX	Viking Therapeutics, Inc.	57,854	$2,256,884
6	MDGL	Madrigal Pharmaceuticals, Inc. This page	3,677	$1,974,365
7	ZYME	Zymeworks Inc.	71,660	$1,873,192
8	IONS	Ionis Pharmaceuticals Inc	23,272	$1,845,236

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,974,365	3,677	+15.0%	Shares	Sole	2026-08-13
2026-03-31	$1,673,533	3,197	+11.5%	Shares	Sole	2026-05-14
2025-12-31	$1,668,986	2,866	-9.9%	Shares	Sole	2026-02-05
2025-09-30	$1,458,997	3,181	+10.3%	Shares	Sole	2025-11-10
2025-06-30	$872,511	2,883	-2.4%	Shares	Sole	2025-08-13
2025-03-31	$978,122	2,953	-28.9%	Shares	Sole	2025-05-15
2024-12-31	$1,280,874	4,151	+15.8%	Shares	Sole	2025-02-06
2024-09-30	$760,596	3,584	-3.5%	Shares	Sole	2024-11-13
2024-06-30	$1,040,234	3,713	+13.4%	Shares	Sole	2024-08-27
2024-03-31	$874,556	3,275	+3.3%	Shares	Sole	2024-05-15
2023-12-31	$733,705	3,171	+4.1%	Shares	Sole	2024-02-07
2023-09-30	$444,983	3,047	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.